Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

This study has been terminated.

( All 29 subjects tested negative for the BRCA2 mutation and so the PI made the decision to discontinue the study due to low enrollment. )

Study NCT00386399 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: October 10, 2006 Last Updated: February 7, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	February 2008
Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)